Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies
Funding comes on the heels of positive top-line clinical results and will advance clinical development of its lead drug candidate Series A led by Sofinnova Partners and OMX Ventures December 12, 2023 05:00 AM Pacific…